Find

Department of Clinical Medicine

Medical/Steno Aarhus Research Laboratory

Publications

Search for a publication

List of publications

Sort by: Date | Author | Title

Aguayo, G. A., Pastore, J., Backes, A., Stranges, S., Witte, D. R., Diederich, N. J., Alkerwi, A., Huiart, L., Ruiz-Castell, M., Malisoux, L., Fagherazzi, G. & Oriscav-Lux Study Group (2022). Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study. Diabetes & Metabolism, 48(1), Article 101263. https://doi.org/10.1016/j.diabet.2021.101263

Ahring, K. K., Dagnæs-Hansen, F., Brüel, A., Christensen, M., Jensen, E., Jensen, T. G., Johannsen, M., Johansen, K. S., Lund, A. M., Madsen, J. G., Brøndum-Nielsen, K., Pedersen, M., Sørensen, L. K., Kjolby, M. & Møller, L. B. (2022). The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model. PLoS One, 17(1), Article e0261150. https://doi.org/10.1371/journal.pone.0261150

Al-Mashhadi, Z. K., Viggers, R., Fuglsang-Nielsen, R., Vestergaard, P., Gregersen, S. & Starup-Linde, J. (2022). Fracture risk in treatment with GLP-1RA compared to DPP-4i: a Danish nationwide cohort study. Diabetologia, 65(SUPPL 1), S183.

Al-Mashhadi, Z., Viggers, R., Linde, J. S., Vestergaard, P. & Gregersen, S. (2022). SGLT2 inhibitor treatment does not increase risk of osteoporotic fractures compared to GLP-1 receptor agonists: a Danish population-based cohort study. Endocrine Abstracts, 81, Article OC8.2. https://doi.org/10.1530/endoabs.81.OC8.2

Al-Mashhadi, Z. K., Viggers, R., Starup-Linde, J., Vestergaard, P. & Gregersen, S. (2022). SGLT2 inhibitor treatment is not associated with an increased risk of osteoporotic fractures when compared to GLP-1 receptor agonists: A nationwide cohort study. Frontiers in Endocrinology, 13, Article 861422. https://doi.org/10.3389/fendo.2022.861422

Al-Mashhadi, Z. K., Viggers, R., Fuglsang-Nielsen, R., Vestergaard, P., Gregersen, S. & Starup-Linde, J. (2022). The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study. Frontiers in Endocrinology, 13, Article 882998. https://doi.org/10.3389/fendo.2022.882998

AlZaim, I. & Kalucka, J. (2022). Batokine neuregulin 4 promotes atherosclerotic resolution. Nature Metabolism, 4(11), 1440-1441. https://doi.org/10.1038/s42255-022-00669-8

Andersen, R. S. & Offersen, S. M. H. (2022). Kunsten at være syg alene: Er det et problem for sundhedsvæsnet at stadig flere mennesker bor alene? Practicus, 2022(260), 26-28. Article 260.

Andersen, N. H., Hauge, E.-M., Baad-Hansen, T., Groth, K. A., Berglund, A., Gravholt, C. H. & Stochholm, K. (2022). Musculoskeletal diseases in Marfan syndrome: a nationwide registry study. Orphanet Journal of Rare Diseases, 17, Article 118. https://doi.org/10.1186/s13023-022-02272-2

Andersen, J. D., Folkestad, L., Hald, J. D., Harsløf, T., Langdahl, B. L. & Abrahamsen, B. (2022). Osteoarthritis in osteogenesis imperfecta: A nationwide register-based cohort study. Bone, 154, Article 116222. https://doi.org/10.1016/j.bone.2021.116222

Displaying results 1011 to 1020 out of 4020

102

Revised 11.09.2025

-

Department of Clinical Medicine